Pharmaceuticals
Company Overview of Bristol-Myers Squibb Sarl
Executive Profile
Peter R. DolanChairman of the Board, Chief Executive Officer and President, Bristol-Myers Squibb Sarl |
| Age | Total Calculated Compensation | This person is connected to 4 Board Members in 4 different organizations across 5 different industries. See Board Relationships |
| 56 | -- |
Background
Prof. Peter R. Dolan BA, MBA is the Chairman at Gemin X Pharmaceuticals, Inc. He serves as a Director of The Vitality Group, Inc. and Vitality Group Limited. Prof. Dolan is a Member of the Advisory Board of Valence Life Sciences. He was the Chief Executive Officer of Gemin X Pharmaceuticals, Inc. Prof. Dolan served as the Chief Executive Officer of Bristol-Myers Squibb Sarl (also known as Bristol-Myers Squibb France), since May 1, 2001 and its President since January ...
Corporate Headquarters3 Rue Joseph MonierRueil Malmaison, Ile-de-France 92500 France Phone: 33 1 58 83 60 00 Fax: 33 1 58 83 60 01 Board Members MembershipsChairman Director Director 2000-2006 Former Director 2000-Present Chairman of the Board, Chief Executive Officer and President 2001-2006 Former Director 2008-Present Chairman and Chief Executive Officer
EducationBA 1978 Tufts University MBA 1980 Tuck School of Business at Dartmouth
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Field, KY | Shire PharmaceuticalsPosted: May 18
- Field, KY | Shire PharmaceuticalsPosted: May 18
- Chesterbrook, PA | Shire PharmaceuticalsPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
To contact Bristol-Myers Squibb Sarl, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








